Mobile application to collect PRO data in NET patients
Research type
Research Study
Full title
A study to assess use of a mobile device technology to collect patient reported symptoms during medical and surgical therapy for neuroendocrine tumours.
IRAS ID
259461
Contact name
Rajaventhan Srirajaskanthan
Contact email
Sponsor organisation
King's College Hospital NHS Foundation Trust
Duration of Study in the UK
6 years, 4 months, 31 days
Research summary
Neuroendocrine tumours (NET) are uncommon cancers with varied presentation. Patients are treated in specialist centres, and may sometimes have up to 4 lines of treatment; with the attendant complications. To date there has been no study capturing precisely patient reported outcomes (PROMs) and changes in QoL post treatment.
We have worked with the national patient charity and support group (Neuroendocrine Tumour Patient Foundation) and UKINETS, to develop a mobile application that will allow patients to capture details of their symptoms, as well as changes to quality of life during and post treatment. The application has been designed as an aide to patients, capturing details of their illness, treatment and interaction with the healthcare team (appointments).
This study aims to assess whether use of mobile app technology is helpful for patients undergoing medical and surgical therapy for neuroendocrine tumours. The trial is non-invasive and allows participants to record daily symptoms and raise alerts whilst they are undergoing different therapies. Health related quality of life during therapy will be assessed at specified times using EORTC validated questionnaires. The study also aims to investigate any difference in clinicians' response to PROMs; and the time taken to institute change, in any.
REC name
HSC REC B
REC reference
20/NI/0021
Date of REC Opinion
6 Mar 2020
REC opinion
Further Information Favourable Opinion